APPLICATION
ANDA210901
TYPE
ANDA
ORIGINAL APPROVAL
2020-01-28
LATEST ACTION
2023-04-27
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Prescription
Products
OLOPATADINE HYDROCHLORIDEPrescription
OLOPATADINE HYDROCHLORIDE 0.665MG/SPRAY · SPRAY, METERED · NASAL
Approval history
2023-04-27Labeling · Supplement 4 · standardAP
2020-01-28UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.